Certified by Founder Lodge
Attovia Therapeutics
United States - Fremont, California
START UP
1 Disclosed Funding Rounds $105,000,000
0 Participating Investments
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
Attovia is creating a pipeline of biotherapeutics with an initial focus on immune-mediated disease and oncology. We leverage ATTOBODY, a novel biologics platform, to generate small format bip
| Date | Round | Raised | Participating Investors |
|---|---|---|---|
| May, 14 ,2024 | Series B | $105,000,000 | |
| April, 17 ,2025 | Series C | $90,000,000.00 | |
| April, 17 ,2025 | Series C | $90,000,000.00 |
Goldman Sachs
Illumina Ventures
Marshall Wace
Redmile Group
EcoR1 Capital, LLC
Frazier Life Sciences
Nextech Ventures
Carmot Therapeutics, Inc.
Ozette Technologies
NAPIGEN, INC.
TrueBinding
Loopworm
Acurion, Inc. | $4,300,000 | (Apr 3, 2026)
EnerVenue | $300,000,000 | (Apr 3, 2026)
Monarch Quantum | $55,000,000 | (Apr 3, 2026)
Numos | $4,250,000 | (Apr 3, 2026)
Gander Robotics | $1,100,000 | (Apr 3, 2026)
